Novartis AG
NVSEF
$111.44
$1.471.33%
Weiss Ratings | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B- | |||
Rating Factors | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Weak | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.58 | |||
Price History | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.31% | |||
30-Day Total Return | 6.79% | |||
60-Day Total Return | 19.93% | |||
90-Day Total Return | 10.82% | |||
Year to Date Total Return | 18.90% | |||
1-Year Total Return | 19.42% | |||
2-Year Total Return | 36.37% | |||
3-Year Total Return | 42.85% | |||
5-Year Total Return | 48.42% | |||
52-Week High % Change | -13.23% | |||
52-Week Low % Change | 18.79% | |||
Price | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $123.55 | |||
52-Week Low Price | $90.24 | |||
52-Week Low Price (Date) | Apr 18, 2024 | |||
52-Week High Price (Date) | Sep 03, 2024 | |||
Valuation | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 212.41B | |||
Enterprise Value | 231.06B | |||
Price/Earnings (TTM) | 18.23 | |||
Earnings Per Share (TTM) | 5.88 | |||
Earnings Per Share Growth | -17.71% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 4.15 | |||
Price/Book (Q) | 4.81 | |||
Enterprise Value/Revenue (TTM) | 4.46 | |||
Price | $111.44 | |||
Enterprise Value/EBITDA (TTM) | 11.64 | |||
Enterprise Value/EBIT | 13.99 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.00B | |||
Dividend Yield | 3.26% | |||
Div. Per Share (Most Recent) | $3.50 | |||
Dividend Per Share (TTM) | $3.50 | |||
Payout Ratio (TTM) | 63.85% | |||
Dividend Per Share (Most Recent) | $3.50 | |||
Company Info | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 41 61 324 11 11 | |||
Address | -- | |||
Website | www.novartis.com | |||
Country | Switzerland | |||
Year Founded | 1996 | |||
Profitability | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 31.89% | |||
Profit Margin | 23.08% | |||
Management Effectiveness | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 10.20% | |||
Return on Equity | 26.28% | |||
Income Statement | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 50.32B | |||
Total Revenue (TTM) | 51.72B | |||
Revenue Per Share | $25.81 | |||
Gross Profit (TTM) | 38.91B | |||
EBITDA (TTM) | 19.84B | |||
EBIT (TTM) | 16.50B | |||
Net Income (TTM) | 11.94B | |||
Net Income Avl. to Common (TTM) | 11.94B | |||
Total Revenue Growth (Q YOY) | 15.13% | |||
Earnings Growth (Q YOY) | 6.90% | |||
EPS Diluted (TTM) | 5.88 | |||
EPS Diluted Growth (Q YOY) | -65.63% | |||
Balance Sheet | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 13.35B | |||
Cash Per Share (Q) | $6.66 | |||
Total Current Assets (Q) | 29.70B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 44.13B | |||
Current Ratio (Q) | 1.035 | |||
Book Value Per Share (Q) | $22.30 | |||
Total Assets (Q) | 102.25B | |||
Total Current Liabilities (Q) | 28.69B | |||
Total Debt (Q) | 31.40B | |||
Total Liabilities (Q) | 58.12B | |||
Total Common Equity (Q) | 44.05B | |||
Cash Flow | NVSEF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -7.51B | |||
Cash from Financing (TTM) | -11.74B | |||
Net Change in Cash (TTM) | -1.93B | |||
Levered Free Cash Flow (TTM) | 11.15B | |||
Cash from Operations (TTM) | 17.62B | |||